H5569 creates a new chapter in Rhode Island insurance law to regulate the sale of pet insurance. The bill defines key terms such as pet insurance, preexisting condition, hereditary disorder, congenital anomaly, waiting period, veterinary expenses, and wellness program, and requires insurers to use those definitions in policy language and on their websites. It also establishes a framework for consumer disclosures, including explanations of exclusions, waiting periods, deductibles, coinsurance, annual or lifetime limits, claim-payment methods, and any relationship between the marketing brand and the underwriting company.
The bill sets policy standards for pet insurance products. It allows exclusions for preexisting conditions, but places the burden on the insurer to prove the exclusion applies. It limits waiting periods for illness and orthopedic conditions to 30 days, prohibits waiting periods for accident coverage, and requires certain waiting-period waivers to be available after a veterinary exam. It also bars insurers from requiring a veterinary exam for renewal, restricts the use and marketing of wellness programs so they are not confused with insurance, and requires producer training on pet insurance-specific topics before sales activity begins.
The bill’s impact on state law is to add a comprehensive regulatory scheme for pet insurance under Title 27, while preserving the application of other insurance laws unless this new chapter specifically overrides them. It also subjects violations to existing insurance penalties under § 42-14-16. The act would apply to pet insurance policies sold, solicited, negotiated, offered, issued, or delivered in Rhode Island, and it is scheduled to take effect on January 1, 2026.
The general sentiment around the bill appears strongly favorable. The House Committee on Corporations passed the substitute version unanimously, and the full House passed the bill 64-1, indicating broad support for regulating a growing insurance product and improving consumer transparency. The near-unanimous votes suggest the bill was viewed as a consumer-protection measure rather than a controversial policy change.
The main points of contention, to the extent they appear in the text and structure of the bill, involve how much flexibility insurers retain versus how much consumer protection is required. The bill permits preexisting-condition exclusions and wellness-program offerings, but only with strict disclosure and separation requirements, and it imposes limits on waiting periods and marketing practices. Potential concerns likely center on administrative burden for insurers and producers, the cost of compliance, and how the rules will affect pricing and product design, though the available vote history shows little overt opposition.
The bill adds a new Chapter 83 to Title 27 of the Rhode Island General Laws, creating a detailed regulatory framework for pet insurance. It requires standardized definitions, mandated disclosures, consumer free-look rights, limits on waiting periods, rules for preexisting-condition exclusions, restrictions on wellness-program marketing, and producer training requirements. Existing insurance laws continue to apply unless specifically superseded by the new chapter, and violations are enforceable through the state’s insurance penalty provisions.
The bill appears to have been received positively and with little controversy. It passed the House Committee on Corporations unanimously and then passed the full House by a wide margin of 64-1, suggesting broad bipartisan support for consumer protections and clearer regulation of pet insurance. The voting record indicates the measure was not viewed as politically divisive.
The principal tension in the bill is between consumer protection and insurer flexibility. Insurers may still exclude preexisting conditions and use waiting periods, but they must disclose those terms clearly and bear the burden of proving exclusions apply. The bill also restricts how wellness programs can be marketed and sold, which may concern insurers and producers that offer bundled or adjacent products. Another likely point of concern is compliance cost, especially for disclosure, training, and website-posting requirements, though the recorded votes show minimal public opposition.